Approved Hospital Formulary
Add Formweb to your mobile device
Search results for:
DOXOrubicin-dacarbazine
DOXOrubicin-dacarbazine
| Form | Strength |
|---|---|
| SOLUTION, INTRAVENOUS |
Additional Information:
Last updated: Mar. 30, 2022
- High Alert: CAUTION: See High-Alert Medication Policy
- Antineoplastic HD PPE and Disposal (doxorubicin)
- Antineoplastic HD PPE and Disposal (dacarbazine)
- Antineoplastic HD Hazardous Drug Safe Handling Policy
- Black Box Warning: doxorubicin: Cardiac, hepatic, myelosuppression, extravasation risk
- Black Box Warning: dacarbazine: Hemopoietic depression; hepatic necrosis risk